Research Article
Which Groups of Children Are at More Risk of Fatality during COVID-19 Pandemic? A Case-Control Study in Yazd, Iran
Table 3
Signs and symptoms in preadmission and on-admission time in deceased and survived children with COVID-19.
| Variables | Preadmission (OR ref: survived group) | On-admission (OR ref: survived group) | Deceased (n = 24) | Survived (n = 167) | | OR (95% CI) | Deceased (n = 24) | Survived (n = 167) | | OR (95% CI) |
| Fever | 17 (70.8%) | 111 (66.4%) | 0.67 | 1.22 (0.48–3.12) | 18 (75%) | 104 (62.27%) | 0.22 | 1.81 (0.68–4.82) | Vomiting | 10 (41.66%) | 46 (27.5%) | 0.15 | 1.88 (0.78–4.53) | 9 (37.5%) | 37 (22.15%) | 0.1 | 2.1 (0.85–5.2) | Cough | 7 (29.1%) | 55 (32.9%) | 0.71 | 0.84 (0.33–2.14) | 4 (16.66%) | 55 (32.9%) | 0.10 | 0.4 (0.13–1.25) | Diarrhea | 6 (25%) | 49 (29.34%) | 0.66 | 0.8 (0.3–2.14) | 7 (29.16%) | 41 (24.5%) | 0.62 | 1.26 (0.49–3.26) | Dyspnea | 6 (25%) | 46 (27.5%) | 0.79 | 0.88 (0.33–2.34) | 9 (37.5%) | 33 (19.76%) | 0.05 | 2.44 (0.98–6.05) | Seizure | 2 (8.3%) | 20 (11.97%) | 0.6 | 0.67 (0.15–3.06) | 2 (8.2%) | 19 (11.37%) | 0.66 | 0.7 (0.15–3.25) | Myalgia | 1 (4.1%) | 27 (16.16%) | 0.12 | 0.22 (0.03–1.74) | 1 (4.1%) | 18 (10.77%) | 0.48 | 0.36 (0.05–2.83) | Cyanosis | 0 | 4 (2.3%) | 1.00 | — | 1 (4.1%) | 7 (4.19%) | 0.99 | 0.99 (0.18–8.45) | Headache | 0 | 25 (14.9%) | 0.15 | 0.25 (0.03–1.91) | 1 (4.1%) | 15 (8.9%) | 0.27 | 0.44 (0.06–3.5) |
|
|
Dyspnea on admission was observed significantly more in the deceased group compared to the survived group.
|